Stock Earnings

Question 1

Quels sont les états financiers clés de Anthera Pharmaceuticals Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Anthera Pharmaceuticals Inc a un total d'actifs de $3, un bénéfice net loss de $-29

Question 2

Quels sont les ratios financiers clés pour ANTH ?

Accepted Answer

Le ratio de liquidité de Anthera Pharmaceuticals Inc est 0.33, la marge nette est 0, les ventes par action sont de $0.

Question 3

Comment les revenus de Anthera Pharmaceuticals Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Anthera Pharmaceuticals Inc data is not available.

Question 4

Anthera Pharmaceuticals Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Anthera Pharmaceuticals Inc a un bénéfice net loss de $-29

Question 5

Anthera Pharmaceuticals Inc a-t-elle des passifs ?

Accepted Answer

yes, Anthera Pharmaceuticals Inc a un passif de 9

Question 6

Combien d'actions en circulation Anthera Pharmaceuticals Inc a-t-elle ?

Accepted Answer

Anthera Pharmaceuticals Inc a un total d'actions en circulation de 13.85

Breakdown	TTM	12/31/2017	12/31/2016	12/31/2015	12/31/2014	12/31/2013
Revenue	0	0	0	3	0	0
Revenue Growth (YoY)	--	--	-100%	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	8	7	11	7	6	6
Research & Development	28	28	46	33	21	21
Operating Expenses	36	36	57	38	28	28
Other Non Operating Income (Expenses)	13	9	1	0	0	0
Pretax Income	-23	-26	-55	-35	-29	-30
Income Tax Expense	--	0	--	--	0	0
Net Income	-24	-29	-66	-35	-29	-30
Net Income Growth	-65%	-56%	89%	21%	-3%	-33%
Shares Outstanding (Diluted)	22.16	10.27	5.16	4.45	2.72	2.28
Shares Change (YoY)	227.99%	99%	16%	64%	19%	153%
EPS (Diluted)	-1.12	-2.85	-12.86	-7.9	-10.87	-13.51
EPS Growth	-89%	-78%	63%	-27%	-20%	-73%
Free Cash Flow	-31	-36	-49	-30	-25	-31
Free Cash Flow Per Share	-1.39	-3.5	-9.48	-6.73	-9.18	-13.57
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	-1,166.66%	0%	0%
Profit Margin	0%	0%	0%	-1,166.66%	0%	0%
Free Cash Flow Margin	0%	0%	0%	-1,000%	0%	0%
EBITDA	-36	-36	-57	-35	-28	-28
EBITDA Margin	0%	0%	0%	-1,166.66%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-36	-36	-57	-35	-28	-28
EBIT Margin	0%	0%	0%	-1,166.66%	0%	0%
Effective Tax Rate	--	0%	--	--	0%	0%

Anthera Pharmaceuticals Inc (ANTH) Price